New bismuth‐containing quadruple therapy in patients infected with <i>Helicobacter pylori</i>: A first Italian experience in clinical practice

Abstract

Pylera^® achieved a remarkable eradication rate in clinical practice, irrespective if it was used as first treatment or as a rescue therapy. Treatment-emergent adverse events were uncommon generally mild.